Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
Appointed director
|
|
AMARIN CORP PLC (AMRN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/10/2022 |
8-K
| Appointed a new director|
Docs:
|
"Amarin Provides Preliminary 2021 Revenue and Outlook for 2022 DUBLIN, Ireland and BRIDGEWATER, N.J., January 10, 2022 -- Amarin Corporation plc today provided a business update, including preliminary unaudited full-year 2021 revenue results. Amarin plans to discuss these results and expectations with investors in connection with the 40th Annual J.P. Morgan Healthcare Conference at which Amarin is scheduled to present virtually on Tuesday, January 11, 2022, at 8:15 am Eastern time. Preliminary 2021 Financial Results Revenue Levels: Full-year 2021 total net revenue, subject to audit, are estimated to be approximately $580 million, despite continued impact of global COVID-19 pandemic and generic competition in the United States. Fourth quarter 2021 total revenue is estimated to be approximate...",
"7 US CVD BURDEN EUROPE CVD BURDEN INTERNATIONAL CVD BURDEN" |
|
| 12/12/2012 |
8-K
| Appointed a new director |
| 12/14/2011 |
8-K
| Form 8-K - Current report |
|
|